Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and Effectiveness of Omnitrope®, a Biosimilar Recombinant Human Growth Hormone: More Than 10 Years' Experience from the PATRO Children Study.
Pfäffle R, Bidlingmaier M, Kreitschmann-Andermahr I, Land C, Partsch CJ, Schwab KO, Sommer H, Backeljauw P, Kanumakala S, Loche S, Zouater H, Strasburger CJ. Pfäffle R, et al. Among authors: kanumakala s. Horm Res Paediatr. 2020;93(3):154-163. doi: 10.1159/000508190. Epub 2020 Aug 19. Horm Res Paediatr. 2020. PMID: 32814319 Free article. Clinical Trial.
Safety and Effectiveness of Recombinant Human Growth Hormone in Children with Turner Syndrome: Data from the PATRO Children Study.
Backeljauw P, Kanumakala S, Loche S, Schwab KO, Pfäffle RW, Höybye C, Lundberg E, Battelino T, Kriström B, Giemza T, Zouater H. Backeljauw P, et al. Among authors: kanumakala s. Horm Res Paediatr. 2021;94(3-4):133-143. doi: 10.1159/000515875. Epub 2021 Jul 7. Horm Res Paediatr. 2021. PMID: 34350858 Free PMC article. Clinical Trial.
Safety and effectiveness of Omnitrope® (somatropin) in PATRO Children: a multi-center, post-marketing surveillance study comparison of US and international cohort data.
Backeljauw P, Kanumakala S, Loche S, Schwab KO, Miller BS, Levy R, McCormick K, Zouater H, Zabransky M, Campbell K. Backeljauw P, et al. Among authors: kanumakala s. Eur J Pediatr. 2022 Jun;181(6):2367-2378. doi: 10.1007/s00431-022-04409-8. Epub 2022 Mar 11. Eur J Pediatr. 2022. PMID: 35275291 Free PMC article.
Growth hormone treatment in children with Prader-Willi syndrome: safety and effectiveness data from the PATRO Children study.
Lämmer C, Backeljauw P, Tauber M, Kanumakala S, Loche S, Otfried Schwab K, Pfäffle R, Höybye C, Lundberg E, Dahlgren J, Ek AE, Battelino T, Kriström B, Esmael A, Zabransky M. Lämmer C, et al. Among authors: kanumakala s. Ther Adv Endocrinol Metab. 2024 Sep 29;15:20420188241264343. doi: 10.1177/20420188241264343. eCollection 2024. Ther Adv Endocrinol Metab. 2024. PMID: 39371577 Free PMC article.
Evolving hypopituitarism following cranial irradiation.
Kanumakala S, Warne GL, Zacharin MR. Kanumakala S, et al. J Paediatr Child Health. 2003 Apr;39(3):232-5. doi: 10.1046/j.1440-1754.2003.00119.x. J Paediatr Child Health. 2003. PMID: 12654151
Massive ovarian edema causing early puberty.
Kanumakala S, Warne GL, Stokes KB, Chan YF, Grover S. Kanumakala S, et al. J Pediatr Endocrinol Metab. 2002 Jun;15(6):861-4. doi: 10.1515/jpem.2002.15.6.861. J Pediatr Endocrinol Metab. 2002. PMID: 12099398
26 results